Literature DB >> 2106011

Transport of lead-203 at the blood-brain barrier during short cerebrovascular perfusion with saline in the rat.

R Deane1, M W Bradbury.   

Abstract

Lead transport at the blood-brain barrier has been studied by short (less than 1.5 min) vascular perfusion of one cerebral hemisphere of the rat with a buffered physiological salt solution at pH 7.4 without calcium, magnesium, or bicarbonate and containing 203 Pb-labelled lead chloride. In the absence of complexing agents, 203Pb uptake was rapid, giving a space of 9.7 ml/100 g of wet frontal cortex at 1 min. Lead-203 influx was linear with lead concentration up to 4 microM. Five percent albumin, 200 microM cysteine, or 1 mM EDTA almost abolished 203Pb uptake. Lead-203 entry into brain was uninfluenced by varying the calcium concentration or by magnesium or the calcium blocker methoxyverapamil. Similarly, 1 mM bicarbonate or 50 microM 4,4'-diisothiocyanostilbene-2,2'-disulphonic acid was without effect. Increasing the potassium concentration reduced 203Pb uptake. Vanadate at 2 mM, 2 microM carbonyl cyanide 4-(trifluoromethoxy)phenylhydrazone (a metabolic uncoupler), or 2 microM stannic chloride all markedly enhanced lead entry into brain, as did a more alkaline pH (7.80). In conclusion, there is a mechanism allowing rapid passive transport of 203Pb at the brain endothelium, perhaps as PbOH+. Lead uptake into brain via this system is probably made less important by active transport of lead back into the capillary lumen by the calcium-ATP-dependent pump.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2106011     DOI: 10.1111/j.1471-4159.1990.tb02337.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  14 in total

Review 1.  Drug metabolism and pharmacokinetics, the blood-brain barrier, and central nervous system drug discovery.

Authors:  Mohammad S Alavijeh; Mansoor Chishty; M Zeeshan Qaiser; Alan M Palmer
Journal:  NeuroRx       Date:  2005-10

2.  Regulation of brain copper homeostasis by the brain barrier systems: effects of Fe-overload and Fe-deficiency.

Authors:  Andrew D Monnot; Mamta Behl; Sanna Ho; Wei Zheng
Journal:  Toxicol Appl Pharmacol       Date:  2011-02-19       Impact factor: 4.219

3.  High affinity interactions of Pb2+ with synaptotagmin I.

Authors:  Sachin Katti; Bin Her; Atul K Srivastava; Alexander B Taylor; Steve W Lockless; Tatyana I Igumenova
Journal:  Metallomics       Date:  2018-09-19       Impact factor: 4.526

4.  Transport into retina measured by short vascular perfusion in the rat.

Authors:  J A Gratton; S L Lightman; M W Bradbury
Journal:  J Physiol       Date:  1993-10       Impact factor: 5.182

5.  Low levels of copper disrupt brain amyloid-β homeostasis by altering its production and clearance.

Authors:  Itender Singh; Abhay P Sagare; Mireia Coma; David Perlmutter; Robert Gelein; Robert D Bell; Richard J Deane; Elaine Zhong; Margaret Parisi; Joseph Ciszewski; R Tristan Kasper; Rashid Deane
Journal:  Proc Natl Acad Sci U S A       Date:  2013-08-19       Impact factor: 11.205

Review 6.  Molecular targets of lead in brain neurotoxicity.

Authors:  Carla Marchetti
Journal:  Neurotox Res       Date:  2003       Impact factor: 3.911

7.  Interactions between tissue uptake of lead and iron in normal and iron-deficient rats during development.

Authors:  A Crowe; E H Morgan
Journal:  Biol Trace Elem Res       Date:  1996-06       Impact factor: 3.738

Review 8.  Brain barrier systems: a new frontier in metal neurotoxicological research.

Authors:  Wei Zheng; Michael Aschner; Jean-Francois Ghersi-Egea
Journal:  Toxicol Appl Pharmacol       Date:  2003-10-01       Impact factor: 4.219

9.  Assessment of blood-brain barrier permeability using the in situ mouse brain perfusion technique.

Authors:  Rong Zhao; J Cory Kalvass; Gary M Pollack
Journal:  Pharm Res       Date:  2009-04-22       Impact factor: 4.200

10.  Copper transport to the brain by the blood-brain barrier and blood-CSF barrier.

Authors:  Byung-Sun Choi; Wei Zheng
Journal:  Brain Res       Date:  2008-11-05       Impact factor: 3.252

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.